BIOA
BioAge Labs, Inc
6.30$
-1.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.0% | 137.2% | 75.6% | 96.5% | 79.8% | 543.0% | 308.5% | 669.4% | 84.4% | 220.0% | 104.3% | 106.5% | 210.0% | 138.1% | 137.5% | 330.8% | 193.6% | 139.0% | 181.2% | 120.5% | – | – | – | – | – | – | – | – | – | 2.4% | – | 2.2% | 2.3% | – | – | |
| 40.0% | -37.2% | 24.4% | 3.5% | 20.2% | -443.0% | -208.5% | -569.4% | 15.6% | -120.0% | -4.3% | -6.5% | -110.0% | -38.1% | -37.5% | -230.8% | -93.6% | -39.0% | -81.2% | -20.5% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 97.7% | 100.0% | 99.4% | |
| 1,844.2% | 410.4% | 318.5% | 796.1% | 945.1% | 1,027.1% | 762.3% | 1,298.3% | 1,254.9% | 1,450.6% | 1,705.8% | 424.6% | 126.8% | 60.4% | 48.4% | 324.7% | 73.1% | 37.6% | 36.0% | 21.8% | – | – | – | – | – | – | – | – | 765.6% | 822.7% | 901.3% | 796.0% | 736.3% | 994.1% | 847.8% | |
| 375.8% | 62.2% | 141.1% | 437.2% | 515.5% | 272.0% | 312.5% | 574.2% | 401.6% | 538.0% | 369.6% | 178.0% | 100.6% | 95.3% | 35.2% | 219.4% | 200.5% | 56.9% | 56.4% | 36.1% | – | – | – | – | – | – | – | – | 467.8% | 304.3% | 325.3% | 227.5% | 279.1% | 302.7% | 278.5% | |
| 3,017.0% | 1,681.7% | 699.2% | 1,779.9% | 2,159.4% | 2,082.5% | 1,537.7% | 2,360.6% | 2,319.1% | 3,066.3% | 2,807.5% | 829.2% | 473.3% | 252.1% | 142.0% | 915.0% | 406.8% | 150.2% | 163.5% | 1,527.1% | – | – | – | – | – | – | – | – | 1,233.4% | 1,127.0% | 1,226.6% | 1,023.4% | 1,013.1% | 1,296.8% | 1,125.7% | |
| -2,977.0% | 597.1% | 1,037.4% | 2,034.4% | 5,682.7% | 3,409.6% | 1,800.1% | 1,527.2% | -2,303.5% | 6,946.5% | 2,432.2% | 798.4% | -583.3% | -290.1% | -179.5% | -4,488.8% | -500.5% | -189.2% | -244.7% | -1,892.1% | – | – | – | – | – | – | – | – | -1,133.4% | -1,027.0% | -1,126.6% | -923.4% | -915.4% | -1,196.8% | -1,026.3% | |
| – | 1,142.4% | 335.3% | 320.6% | 3,522.7% | 2,979.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 17.6% | 8.3% | 7.3% | 3.0% | 1.4% | 0.0% | 2.7% | |
| -3,094.0% | 597.1% | 1,037.4% | 2,034.4% | 5,682.7% | 3,409.6% | 1,800.1% | 1,527.2% | -2,433.0% | 6,946.5% | 2,432.2% | 798.4% | -859.1% | 116.8% | -183.5% | -4,488.8% | -64.3% | -214.6% | -237.9% | -1,892.1% | – | – | – | – | – | – | – | – | -891.0% | -894.0% | -982.0% | -842.9% | -802.8% | -1,064.7% | -912.3% | |
| -117.0% | 4.5% | 2.6% | 7.7% | 7.2% | 2.3% | 3.8% | 7.3% | 9.1% | -22.6% | 16.8% | -1.7% | 0.4% | 0.5% | -4.0% | 1.2% | 0.6% | 1.4% | -0.6% | 0.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2,872.6% | 592.5% | 1,034.8% | 2,073.5% | 5,689.8% | 3,411.7% | 1,803.9% | 1,534.6% | -2,248.7% | 6,959.3% | 2,424.0% | 797.0% | -750.5% | 190.8% | -168.2% | -4,488.8% | 5.0% | -173.2% | -213.6% | -1,892.1% | – | – | – | – | – | – | – | – | -891.0% | -894.0% | -982.0% | -842.9% | -802.8% | -1,064.7% | -912.3% | |
| -2,690.4% | -481.6% | 1,399.4% | 2,450.7% | 9,298.1% | 505.3% | 1,876.3% | 1,696.7% | -2,089.8% | 7,237.5% | 2,628.5% | 968.3% | -597.2% | 285.2% | -103.2% | -4,141.5% | 91.6% | -126.6% | -152.7% | -1,824.4% | – | – | – | – | – | – | – | – | -870.8% | -883.3% | -972.4% | -837.6% | -799.1% | -1,061.9% | -907.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.